Interest of Procalcitonin in ANCA Vasculitides for Differentiation between Flare and Infections.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
14 Mar 2023
Historique:
received: 30 01 2023
revised: 26 02 2023
accepted: 08 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Procalcitonin (PCT) was established as a biomarker to discriminate bacterial infections from other proinflammatory conditions. Our objective was to determine whether PCT is effective in differentiating infection from antineutrophil-cytoplasmic-antibody (ANCA)-associated vasculitides (AAV) flare. In this retrospective, case-control study, PCT and other inflammatory biomarkers of patients with AAV relapse (relapsing group) were compared to infected AAV patients (infected group). In our population of 74 patients with AAV, PCT was significantly higher in the infected group than in the relapsing group (0.2 µg/L [0.08; 0.935] vs. 0.09 µg/L [0.05; 0.2],

Identifiants

pubmed: 36982631
pii: ijms24065557
doi: 10.3390/ijms24065557
pmc: PMC10052072
pii:
doi:

Substances chimiques

Procalcitonin 0
Antibodies, Antineutrophil Cytoplasmic 0
Biomarkers 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet. 1993 Feb 27;341(8844):515-8
pubmed: 8094770
J Rheumatol. 1998 Aug;25(8):1531-3
pubmed: 9712096
Lancet. 2004 Feb 21;363(9409):600-7
pubmed: 14987884
Arthritis Rheum. 1997 Jul;40(7):1250-6
pubmed: 9214425
J Rheumatol. 2012 Aug;39(8):1517-23
pubmed: 22753652
Crit Care Med. 2018 May;46(5):691-698
pubmed: 29271844
Intensive Care Med. 2015 Jan;41(1):12-20
pubmed: 25319385
Mod Rheumatol. 2014 May;24(3):457-63
pubmed: 24252006
Nephrol Dial Transplant. 2001 May;16(5):980-6
pubmed: 11328904
Clin Infect Dis. 2014 Dec 15;59(12):1761-7
pubmed: 25228701
Crit Care Med. 2000 Feb;28(2):458-61
pubmed: 10708183
Ann Rheum Dis. 2001 Oct;60(10):988-9
pubmed: 11589181
J Clin Endocrinol Metab. 1994 Dec;79(6):1605-8
pubmed: 7989463
Eur J Anaesthesiol. 2001 Feb;18(2):79-87
pubmed: 11270029
Lupus. 2013 Oct;22(11):1102-9
pubmed: 23934401
Lupus. 2019 Oct;28(11):1329-1336
pubmed: 29779437
Intensive Care Med. 2000 Mar;26 Suppl 2:S212-6
pubmed: 18470722
Open Rheumatol J. 2015 Oct 09;9:71-6
pubmed: 26535070
Crit Care. 2014 Nov 19;18(6):640
pubmed: 25407928
Arthritis Rheum. 2001 Apr;44(4):912-20
pubmed: 11318006
PLoS One. 2015 Apr 20;10(4):e0123358
pubmed: 25894539
Infection. 1998 Sep-Oct;26(5):274-6
pubmed: 9795783
Ann Rheum Dis. 2007 Feb;66(2):222-7
pubmed: 16901958
Lupus. 2012 Oct;21(11):1172-7
pubmed: 22652631
J Rheumatol. 2012 Apr;39(4):728-34
pubmed: 22337236
Swiss Med Wkly. 2005 Aug 6;135(31-32):451-60
pubmed: 16208582
Arthritis Rheum. 1990 Aug;33(8):1068-73
pubmed: 2202306
Pract Lab Med. 2015 Jul 17;2:22-28
pubmed: 28932801
Clin Rheumatol. 2019 Apr;38(4):997-1005
pubmed: 30446886
Ann Rheum Dis. 2011 Mar;70(3):488-94
pubmed: 21109517
Infection. 2008 Mar;36(2):163-6
pubmed: 18330505
Arthritis Rheum. 2013 Jan;65(1):1-11
pubmed: 23045170
Crit Care Med. 2000 Apr;28(4):1040-6
pubmed: 10809279

Auteurs

Xavier Poirot-Seynaeve (X)

Médecine Interne, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.

Perrine Smets (P)

Médecine Interne, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.

Bruno Pereira (B)

Biostatistics Unit (DRCI), University Hospital Clermont-Ferrand, 63000 Clermont-Ferrand, France.

Louis Olagne (L)

Médecine Interne, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.

Julien Stievenart (J)

Médecine Interne, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.

Vincent Sapin (V)

Biochemisty and Molecular Genetic Department, Biology Center, University Hospital Clermont-Ferrand, 63000 Clermont-Ferrand, France.

Olivier Aumaitre (O)

Médecine Interne, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.
M2iSH, UMR 1071 Inserm, INRA USC 2018, University of Clermont Auvergne, 63000 Clermont-Ferrand, France.

Marc Andre (M)

Médecine Interne, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.
M2iSH, UMR 1071 Inserm, INRA USC 2018, University of Clermont Auvergne, 63000 Clermont-Ferrand, France.

Ludovic Trefond (L)

Médecine Interne, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France.
M2iSH, UMR 1071 Inserm, INRA USC 2018, University of Clermont Auvergne, 63000 Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH